November 19, 2012
November 19, 2012 —
For work toward a safer approach to treating cancer, electrical engineering Ph.D. student Inanc Ortac from the University of California, San Diego has won first prize in the graduate student category at the 2012 Collegiate Inventors Competition.
June 9, 2022
June 9, 2022 —
An international team of researchers, led by scientists at University of California San Diego School of Medicine and the University of Pittsburgh, report promising results from the largest case series yet of patients treated with bacteriophage therapy for antibiotic-resistant infections.
March 26, 2012
March 26, 2012 —
Repeated stress triggers the production and accumulation of insoluble tau protein aggregates inside the brain cells of mice, say researchers at the University of California, San Diego School of Medicine in a new study published in the March 26 Online Early Edition of the Proceedings of the National Academy of…
February 16, 2022
February 16, 2022 —
UC San Diego researchers discover a specific antimicrobial skin cell and the role it plays in acne development, which could result in more targeted treatment options.
December 6, 2011
December 6, 2011 —
…develop a novel cellular therapy for ALS. Their work focuses on investigating how motor neurons form and make their predetermined connections between the spinal cord and the muscles in the body. ALS is a devastating disease marked by motor neuron degeneration, leading to extreme muscle weakness, paralysis and death. Previous…
June 28, 2017
June 28, 2017 —
Using a novel molecular dynamics method capable of capturing the motion of gyrating proteins at time intervals up to one thousand times greater than previous efforts, a team led by UC San Diego researchers has identified, for the first time, the myriad structural changes that activate and drive CRISPR-Cas9, the…
October 22, 2020
October 22, 2020 —
UC San Diego researchers use experimental artificial intelligence system called DrugCell to predict the best approach to treating cancer. Only 4 percent of all cancer therapeutic drugs under development earn final approval by the U.S. Food and Drug Administration (FDA).
May 6, 2022
May 6, 2022 —
UC San Diego researchers describe the underlying signaling pathway that results in pulmonary arterial hypertension and a novel monoclonal antibody therapy that blocks the abnormal blood vessel formation characterizing the disease.
March 14, 2019
March 14, 2019 —
A new paper by UC San Diego researchers hypothesizes a possible link between cancer-causing viruses.
June 22, 2021
June 22, 2021 —
Longtime supporters of cancer research and patient care at Moores Cancer Center at UC San Diego Health have given University of California San Diego School of Medicine $2 million to establish the Iris and Matthew Strauss Chancellor’s Endowed Chair in Head and Neck Surgery.